•Developed new product for calculating genetic risk scores for multiple common cancer diseases based on genetic markers.
•Examined availability of genetic markers of interest in Illumina GSA chip, resulting in a more-informed business decision.
•Performed meta-analysis of consortia for different diseases and conditions for genetic marker selection and evaluation, aiming to design a comprehensive custom chip for genetic screening.
•Developed protocol and web-crawler to find known biomarkers for a given disease, accelerating preliminary research.
